VIR: Vir Biotechnology, Inc.
Performance
VIR +165.98%
Watchlist
Select an item
Summary
VIR at a glance
VIR returned +165.98% over the past year and -15.24% a year over five years. Its worst drop in that year was -25.61%, smaller than 68% of stocks on Redstone, and its Sharpe ratio of 1.76 beats 96% of stocks on Redstone. It pays no dividends.
Current Drawdown
0.00%
Rolling Volatility
77.50%
Actions
Metrics
Risk Indicators
Alpha97.71%
Beta1.80x
Sharpe1.76
Sortino3.16
Omega1.35
Calmar6.48
Martin10.38
Profile
About VIR
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $2.3B
- Listed
- Oct 2019
- Employees
- 367
- Headquarters
- San Francisco, CA
- Website
- vir.bio
Comparisons